<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Part 1. Patient Evaluation and Laboratory Safety

Download the Presentation: Click here to download the presentation

Part 2. Fertility Treatment for Infected Patients

Download the Presentation: Click here to download the presentation

Featured Speaker:

Erma Z. Drobnis, PhD
Clinical Assistant Professor
University of Missouri, Columbia
Obstetrics, Gynecology & Women’s Health
Laboratory Director, Reproductive Medicine & Fertility

Learning Objectives:
At the conclusion of this presentation, participants should be able to:

  • List the four reasons why infectious diseases are of concern in treating infertility patients
  • Identify the disease organisms for which fertility patients embarking on assisted reproduction are currently screened
  • Identify measures to protect clinic personnel when treating patients with viral infections like HIV and HCV and how cross-contamination of patient reproductive tissue is prevented
  • Describe how preventative measures differ between viral infections for serodiscordant couples using fertility services to produce a biologically related child
  • Counsel patients serodiscordant for a viral infection on the risks of proceeding with fertility treatment to produce a biologically related child